Clinical Trials

New Search
Title   A Phase II Multi-Center, Randomized, Double-Blind, 24-Week, Parallel Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Children and Adolescents Age 5-17 With Autism Spectrum Disorder (ASD)
Disease/Condition   Mental Health and Disorders,Autism Spectrum Disorder,Pediatrics,Psychiatry - Non Cancer,Neurodevelopmental Disorders

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Eric Hollander, MD
Contact Name   Danya Schlussel
Contact Email
Protocol Number   16-10-117-01
Inclusion/Notes   This information was obtained from
Status   Active/Enrolling
Adult Clinical Trial   No
Pediatric Clinical Trial   Yes
Sub-Specialty   Brain and Nervous System - Autism Spectrum Disorder
Adult, Pediatric, Both   Pediatric